Americas

News and reports from North, Central and South America.

Fobi Integrates With Square, Offering Real-Time Data Analytics to Retailers Around the Globe

Fobi AI Inc. (FOBI: TSXV; FOBIF: OTCQB) (the “Company” or “FOBI”), a leader in providing real-time data analytics through artificial intelligence to drive customer activation and engagement, is pleased to announce the partnership and integration of its Fobi platform with Square, owned by global technology company, Block, Inc. — formerly Square, Inc. The partnership includes the availability of the Fobi app on the Square App Marketplace for businesses of all types and sizes including those in the retail and food and beverage industries.

UBEO ACQUIRES CENTRIC BUSINESS SYSTEMS, EXPANDS TO MID-ATLANTIC

UBEO Business Services (“UBEO”), one of the largest national providers of business technology and related services, is proud to announce that Centric Business Systems has joined the UBEO family of companies.

UBEO ACQUIRES CENTRIC BUSINESS SYSTEMS, EXPANDS TO MID-ATLANTIC

UBEO Business Services (“UBEO”), one of the largest national providers of business technology and related services, is proud to announce that Centric Business Systems has joined the UBEO family of companies.

Rockridge Resources Reports 4.06% and 1.60% Copper in Grab Samples and Identifies New Target West of Gilbert Lake at its Knife Lake Project

Rockridge Resources Ltd. (TSX-V: ROCK) (OTCQB: RRRLF) (Frankfurt: RR0(“Rockridge” or the “Company”) is pleased to announce further sampling and prospecting results from the 2021 exploration program at the  Knife Lake Copper VMS Project located in Saskatchewan, Canada (the “Knife Lake Project” or “Property”). The Knife Lake Project, consisting of 82 claims totaling 56,865 hectares (140,516 acres), is an advanced-stage copper, silver, zinc and cobalt exploration property in Saskatchewan host to the Knife Lake Deposit.

ProMIS Neurosciences Announces Antibody Program for Schizophrenia Therapy and Recruitment of Dr. Carsten Korth to its Scientific Advisory Board

ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting misfolded proteins such as toxic oligomers implicated in the development of neurodegenerative diseases, announced today that it has initiated a program to develop monoclonal antibodies to treat schizophrenia and other chronic mental illnesses. Schizophrenia is a clinical term for a severely disabling neuropsychiatric disease that disrupts employment, families and communities, and likely has heterogenous biological origins.

Skyharbour’s Partner Company Azincourt Energy Provides Update on Camp Construction and Drill Mobilization at East Preston Uranium Project, Saskatchewan

Skyharbour Resources Ltd.’s (TSX-V:SYH) (OTCQB:SYHBF) (Frankfurt:SC1P) (the “Company”) partner company Azincourt Energy (“Azincourt”) is pleased to announce that construction of the exploration camp for the winter 2022 exploration program is underway at the East Preston uranium project, located in the western Athabasca Basin, Saskatchewan, Canada.

FOBI Announces Definitive Agreement To Acquire Passworks S.A. for €400,000 To Further Expand FOBI's Global Digital Wallet Pass Portfolio

FOBI AI Inc. (TSXV: FOBI, OTCQB: FOBIF) (the "Company" or "FOBI"), a global leader in providing real-time data analytics through artificial intelligence to drive operational efficiencies and profitability, is pleased to announce that it has entered into a share purchase agreement (the "SPA") with Passworks to acquire all of the issued and outstanding shares (the "Target Shares") of Passworks S.A. (the "Transaction"), a leading European digital wallet and mobile marketing company with international clients such as luxury fashion leader Hugo Boss, global coupon giant Catalina Marketing Corporation and media giant Wunderman Thompson UK. 

ProMIS Neurosciences to Participate in the Biotech Showcase 2022 Virtual Panel Discussion: Aduhelm Stimulating the Next Generation of Alzheimer’s Treatment

ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting misfolded proteins such as toxic oligomers implicated in the development of neurodegenerative diseases, announced today its participation in the Biotech Showcase 2022 virtual panel discussion to be held on Jan. 11, 2022 from 8 AM to 9 AM PST.

ProMIS Neurosciences to Participate in H.C. Wainwright BioConnect 2022 Virtual Conference

ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting misfolded proteins such as toxic oligomers implicated in the development of neurodegenerative diseases, announced today its participation in the H.C. Wainwright BioConnect 2022 Virtual Conference being held January 10–13, 2022.

GLOBAL ROBOTIC PROCESS AUTOMATION CONSULTING FIRM NEOSTELLA EARNS UIPATH DIAMOND PARTNER STATUS

Neostella, a robotic process automation consulting and development company headquartered in Milwaukee and with additional offices in London, UK; Medellin, Colombia; and Cebu City, Philippines has just earned Diamond Partner status from leading enterprise Robotic Process Automation (RPA) software company, UiPath Inc. (NYSE: PATH). Diamond level is the highest partnership status available to UiPath partners.

Pages

Subscribe to RSS - Americas